Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Cardiology · Anthracycline-Induced Cardiomyopathy

Symptoms and Warning Signs

At a Glance

Anthracycline-related heart injury may cause no early symptoms, so regular monitoring matters. Report breathlessness, swelling, rapid weight gain, palpitations, unusual fatigue, or nighttime cough promptly, and seek emergency care for severe breathlessness, chest pain, fainting, or blue skin.

The most important thing to know about anthracycline-related heart changes is that early injury is almost always asymptomatic—meaning you will feel perfectly normal even if your heart is under stress [1][2]. This is why your medical team schedules regular echocardiograms and blood tests even when you are feeling well. These tests can “see” what your body cannot yet feel [3][4].

However, if heart muscle changes progress, they can lead to physical symptoms. Because cancer treatment causes many side effects, it can be difficult to tell the difference between “chemo fatigue” and a heart-related issue. Note that many of these symptoms—like shortness of breath or swelling—can also be caused by anemia, infections, blood clots (pulmonary embolism), or fluids given during chemotherapy. Learning these specific warning signs helps you advocate for a prompt medical evaluation.

Recognizing Heart Symptoms

Heart failure symptoms are often related to congestion—the buildup of fluid because the heart is not pumping efficiently [5][6].

  • Exertional Breathlessness: While chemotherapy may make you feel tired, heart-related shortness of breath (dyspnea) typically happens when you move. You may find you get winded doing things that were easy for you just a week or two ago, such as walking to the mailbox [7][8].
  • Positional Breathing Changes: Pay attention to how you feel when lying flat. Orthopnea is the need to prop yourself up with pillows to breathe comfortably [6]. You may also experience paroxysmal nocturnal dyspnea, which is waking up suddenly in the middle of the night gasping for air [9][10].
  • Peripheral Edema: This is swelling caused by fluid buildup, most often seen in the ankles, feet, or legs [5]. If you press your finger into your ankle and it leaves a visible “dent” or “pit” in the skin, this is a sign to report [11].
  • Rapid Weight Gain: Fluid can accumulate quickly. Doctors often recommend weighing yourself every morning. A sudden increase in weight (ask your care team for your specific threshold, but often 2 to 3 pounds in a day or 5 pounds in a week) can be an early sign of fluid retention before you even see swelling [12][13].
  • Palpitations: This feels like your heart is racing, skipping beats, or “flopping” in your chest [8]. While common with caffeine, stress, or anemia, new or frequent palpitations during anthracycline treatment should always be evaluated [14].

Distinguishing Heart Symptoms from Chemo Side Effects

It is normal to feel exhausted during cancer treatment. However, heart-related fatigue is often “out of proportion” to what is expected.

Symptom General Chemo Side Effect Potential Heart Warning Sign
Fatigue General tiredness; improves with rest. Profound exhaustion; gets worse with minor activity [7].
Shortness of Breath May happen if you are very anemic (low red blood cells). Happens specifically when lying flat or during exertion [6].
Nausea Often happens shortly after an infusion; related to digestion. May be accompanied by a “full” or bloated feeling in the abdomen due to fluid buildup [11].
Cough May be a dry “tickle” or related to a cold. A persistent cough, especially at night or when lying down, which does not always have to be “wet” sounding [6].

Triage: When to Seek Help

Use your oncology team’s specific contact plan. You should never stop your chemotherapy or your heart medications without speaking to your doctor first.

Call Your Doctor Promptly

Do not wait for your next scheduled appointment to report these:

  • New or worsening swelling in your ankles, feet, or legs [11].
  • A rapid weight gain that meets your doctor’s specific threshold (often 2+ pounds overnight or 5 pounds in a week) [12].
  • Needing more pillows than usual to breathe comfortably at night [6].
  • New palpitations or a heart rate that feels consistently fast while you are resting [14].
  • A new, persistent cough that is worse when you lie down [6].
  • Profound, unusual fatigue that is suddenly much worse than your baseline chemo fatigue.

Medical Emergency (Call 911 or go to the ER)

  • Sudden, severe shortness of breath, especially if it happens while you are resting [5][15].
  • Chest pain, pressure, or a “heavy” feeling in the chest [14][16].
  • Fainting (syncope) or feeling like you are about to pass out [14].
  • Confusion or sudden mental “fog” combined with breathlessness [5].
  • Blue or gray tint to your lips, skin, or fingernails (indicating low oxygen) [5][15].

Common questions in this guide

Can anthracycline heart damage happen even if I feel well?
Yes. Early heart injury from anthracycline treatment is often symptom-free, so you may feel normal while changes are detected on an echocardiogram or blood test. Keep scheduled monitoring appointments and tell your care team about any new concerns.
What symptoms can signal anthracycline-related cardiomyopathy?
Warning signs can include shortness of breath with activity or when lying flat, waking at night gasping, swelling in the legs or ankles, rapid weight gain, palpitations, unusual fatigue, or a persistent cough that is worse when lying down. These symptoms can have other causes during cancer treatment, so report new or worsening symptoms to your care team.
When should I contact my oncology team about possible heart symptoms?
Call promptly for new leg or ankle swelling, a sudden weight increase, needing more pillows to sleep, new palpitations, a resting heart rate that feels consistently fast, a lying-down cough, or fatigue that is much worse than usual. Ask your team what weight change should trigger a call; common thresholds are about 2 pounds overnight or 5 pounds in a week, but your personal instructions come first.
Which symptoms mean I need emergency help during anthracycline treatment?
Call 911 or go to the emergency department for sudden severe shortness of breath, especially at rest; chest pain, pressure, or heaviness; fainting or near-fainting; confusion with breathlessness; or blue or gray lips, skin, or fingernails. Do not wait for a routine appointment when these symptoms occur.
How can I tell chemotherapy fatigue from a possible heart problem?
General treatment fatigue may improve with rest, while heart-related fatigue can be unusually profound or worsen with minor activity. Because anemia, infection, blood clots, and other treatment effects can cause similar symptoms, your medical team should evaluate a new or rapidly worsening change.
How should I track possible heart symptoms at home?
If your care team recommends it, weigh yourself every morning at about the same time and record your baseline weight. Also note how many pillows you need, whether you wake up gasping, changes in activity tolerance, and swelling or sock marks, then share the record with your team.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my history and the drugs I am receiving, what specific heart symptoms should I be most vigilant for?
  2. 2.If I notice new swelling or a sudden weight gain over the weekend, whom should I call? Is there a cardio-oncology nurse or a 24-hour on-call service?
  3. 3.How do you differentiate between my general treatment fatigue and fatigue that might be related to my heart?
  4. 4.At what point should a change in my shortness of breath during daily activities trigger a new echocardiogram or blood test?
  5. 5.Can we establish what a 'normal' blood pressure and heart rate range is for me during this phase of my treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    The Role of Biomarkers in Cardio-Oncology.

    Ananthan K, Lyon AR

    Journal of cardiovascular translational research 2020; (13(3)):431-450 doi:10.1007/s12265-020-10042-3.

    PMID: 32642841
  2. 2

    Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

    Armenian SH, Hudson MM, Mulder RL, et al.

    The Lancet. Oncology 2015; (16(3)):e123-36.

    PMID: 25752563
  3. 3

    Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.

    Oikonomou EK, Kokkinidis DG, Kampaktsis PN, et al.

    JAMA cardiology 2019; (4(10)):1007-1018 doi:10.1001/jamacardio.2019.2952.

    PMID: 31433450
  4. 4

    Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.

    Demissei BG, Hubbard RA, Zhang L, et al.

    Journal of the American Heart Association 2020; (9(2)):e014708 doi:10.1161/JAHA.119.014708.

    PMID: 31959034
  5. 5

    Iatrogenic Arteriovenous Fistula Secondary to Percutaneous Coronary Intervention Causing Severe Decompensated Heart Failure.

    Kasliwal N, Pfeiffer WB, Eidt JF, et al.

    Cureus 2022; (14(8)):e27934 doi:10.7759/cureus.27934.

    PMID: 36134099
  6. 6

    Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).

    Lala A, McNulty SE, Mentz RJ, et al.

    Circulation. Heart failure 2015; (8(4)):741-8 doi:10.1161/CIRCHEARTFAILURE.114.001957.

    PMID: 26041600
  7. 7

    The Role of Diastolic Stress Echo and Myocardial Work in Early Detection of Cardiac Dysfunction in Women with Breast Cancer Undergoing Chemotherapy.

    Sokratous S, Kyriakou M, Khattab E, et al.

    Biomedicines 2025; (13(10)) doi:10.3390/biomedicines13102341.

    PMID: 41153628
  8. 8

    Anthracyclines and the Heart: A Double-edged Sword With Therapeutic Hopes.

    Alotaibi TM, Samman AM, Al Ghamdi AA, et al.

    Journal of the Saudi Heart Association 2026; (38(1)):2 doi:10.37616/2212-5043.1475.

    PMID: 41768301
  9. 9

    Universal Definition and Classification of Heart Failure.

    Bozkurt B, Coats A, Tsutsui H

    Journal of cardiac failure 2021; doi:10.1016/j.cardfail.2021.01.022.

    PMID: 33662581
  10. 10

    Length of hospital stay and associated factors among heart failure patients admitted to the University Hospital in Northwest Ethiopia.

    Tigabe Tekle M, Bekalu AF, Tefera YG

    PloS one 2022; (17(7)):e0270809 doi:10.1371/journal.pone.0270809.

    PMID: 35867684
  11. 11

    Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial.

    Simonavičius J, Sanders van-Wijk S, Rickenbacher P, et al.

    The American journal of medicine 2019; (132(9)):e679-e692 doi:10.1016/j.amjmed.2019.04.010.

    PMID: 31051151
  12. 12

    Management of Patients Admitted with Acute Decompensated Heart Failure.

    Krim SR, Campbell PT, Desai S, et al.

    Ochsner journal 2015; (15(3)):284-9.

    PMID: 26413005
  13. 13

    Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial.

    Kalter-Leibovici O, Freimark D, Freedman LS, et al.

    BMC medicine 2017; (15(1)):90 doi:10.1186/s12916-017-0855-z.

    PMID: 28457231
  14. 14

    Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.

    Herrmann J, Lenihan D, Armenian S, et al.

    European heart journal 2022; (43(4)):280-299 doi:10.1093/eurheartj/ehab674.

    PMID: 34904661
  15. 15

    Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission.

    Montisci A, Palmieri V, Liu JE, et al.

    Frontiers in cardiovascular medicine 2021; (8()):713694 doi:10.3389/fcvm.2021.713694.

    PMID: 34540917
  16. 16

    Missed or Delayed Diagnosis of Heart Disease by the General Pediatrician.

    Karatza AA, Fouzas S, Gkentzi D, et al.

    Children (Basel, Switzerland) 2025; (12(3)) doi:10.3390/children12030366.

    PMID: 40150649

This page is for informational purposes only and does not constitute medical advice. It explains warning signs of anthracycline-related heart problems; contact your oncology or cardiology team about symptoms and seek emergency care for severe symptoms.

Get notified when new evidence is published on Cardiomyopathy due to anthracyclines.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.